EP 0755262 A4 19970507 - COMPOSITION FOR THE TREATMENT OF LUNG DISEASE
Title (en)
COMPOSITION FOR THE TREATMENT OF LUNG DISEASE
Title (de)
ZUBEREITUNG FÜR DIE BEHANDLUNG VON LUNGENERKRANKUNGEN
Title (fr)
COMPOSITION DE TRAITEMENT DE PNEUMOPATHIE
Publication
Application
Priority
- US 9502938 W 19950307
- US 21242094 A 19940311
Abstract (en)
[origin: WO9524207A1] Disclosed are pharmaceutical compositions for the treatment of lung disease, and in particular Cystic Fibrosis, comprising a substituted azetidinone of general formula (I), which have been found to be potent elastase inhibitors and a (F)-actin shortening protein, such as gelsolin.
IPC 1-7
IPC 8 full level
C07D 205/08 (2006.01); A61K 31/395 (2006.01); A61K 31/397 (2006.01); A61K 31/40 (2006.01); A61K 31/4427 (2006.01); A61K 31/443 (2006.01); A61K 31/445 (2006.01); A61K 31/495 (2006.01); A61K 38/00 (2006.01); A61K 38/17 (2006.01); A61P 9/08 (2006.01); A61P 9/10 (2006.01); A61P 11/00 (2006.01); A61P 11/10 (2006.01); A61P 11/14 (2006.01); A61P 29/00 (2006.01); A61P 31/04 (2006.01); A61P 33/02 (2006.01); C07D 401/12 (2006.01); C07D 403/12 (2006.01); C07D 405/06 (2006.01)
CPC (source: EP US)
A61K 31/395 (2013.01 - EP US); A61K 38/1709 (2013.01 - EP); A61P 9/08 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 11/10 (2017.12 - EP); A61P 11/14 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/04 (2017.12 - EP); A61P 33/02 (2017.12 - EP)
Citation (search report)
- [A] WO 9115770 A1 19911017 - GEN HOSPITAL CORP [US]
- See references of WO 9524207A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9524207 A1 19950914; AU 2099495 A 19950925; AU 686780 B2 19980212; CA 2184385 A1 19950914; EP 0755262 A1 19970129; EP 0755262 A4 19970507; JP H09510212 A 19971014
DOCDB simple family (application)
US 9502938 W 19950307; AU 2099495 A 19950307; CA 2184385 A 19950307; EP 95913618 A 19950307; JP 52364195 A 19950307